AU1410399A - Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell - Google Patents
Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cellInfo
- Publication number
- AU1410399A AU1410399A AU14103/99A AU1410399A AU1410399A AU 1410399 A AU1410399 A AU 1410399A AU 14103/99 A AU14103/99 A AU 14103/99A AU 1410399 A AU1410399 A AU 1410399A AU 1410399 A AU1410399 A AU 1410399A
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- dna
- introduction
- cell
- transfer vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/60—Vectors containing traps for, e.g. exons, promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
- C12N2830/006—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6530397P | 1997-11-13 | 1997-11-13 | |
US60065303 | 1997-11-13 | ||
PCT/US1998/024348 WO1999025817A2 (en) | 1997-11-13 | 1998-11-13 | Tc1-based transposon vectors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1410399A true AU1410399A (en) | 1999-06-07 |
Family
ID=22061760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14103/99A Abandoned AU1410399A (en) | 1997-11-13 | 1998-11-13 | Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1034258A2 (en) |
JP (1) | JP2001523450A (en) |
AU (1) | AU1410399A (en) |
CA (1) | CA2309000A1 (en) |
WO (1) | WO1999025817A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0973928T3 (en) | 1997-03-11 | 2010-08-09 | Univ Minnesota | DNA-based transposon system for introducing nucleic acid into DNA in a cell |
US7160682B2 (en) | 1998-11-13 | 2007-01-09 | Regents Of The University Of Minnesota | Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell |
WO2000068399A2 (en) * | 1999-05-11 | 2000-11-16 | Regents Of The University Of Minnesota | Vector-mediated delivery of integrating transposon sequences |
WO2001029205A2 (en) * | 1999-10-19 | 2001-04-26 | Minos Biosystems Limited | Method for genetic manipulation |
AU1100201A (en) | 1999-10-28 | 2001-05-08 | Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
WO2001055369A1 (en) | 2000-01-28 | 2001-08-02 | The Scripps Research Institute | Synthetic internal ribosome entry sites and methods of identifying same |
CA2407651C (en) * | 2000-04-27 | 2013-07-02 | Max-Delbruck-Centrum Fur Molekulare Medizin | Sleeping beauty, a transposon vector with a broad host range for the genetic transformation in vertebrates |
EP1286699A2 (en) * | 2000-05-19 | 2003-03-05 | Regents Of The University Of Minnesota | Composition for delivery of compounds to cells |
US8227432B2 (en) | 2002-04-22 | 2012-07-24 | Regents Of The University Of Minnesota | Transposon system and methods of use |
DE10224242A1 (en) * | 2002-05-29 | 2003-12-11 | Max Delbrueck Centrum | Frog Prince, a transposon vector for vertebrate gene transfer |
US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
US7919583B2 (en) | 2005-08-08 | 2011-04-05 | Discovery Genomics, Inc. | Integration-site directed vector systems |
CA2692501C (en) | 2007-07-04 | 2017-10-10 | Max-Delbrueck-Centrum Fuer Molekulare Medizin | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
WO2011153440A2 (en) | 2010-06-04 | 2011-12-08 | Regents Of The University Of Minnesota | Transposon mutagenesis system and methods of use |
EP3092308A1 (en) | 2014-01-07 | 2016-11-16 | Fundacio Privada Institut de Medicina Predictiva i Personalitzada del Cancer | Method for generating double stranded dna libraries and sequencing methods for the identification of methylated cytosines |
BR112020000406A2 (en) * | 2017-07-10 | 2022-09-13 | Inst De Biologia Molecular Do Parana Ibmp | GENETIC PLATFORM FOR HETEROLOGOUS OVEREXPRESSION ASSOCIATED WITH THE SELECTION OF HIGHLY PROTEIN PRODUCING CELLS |
JP7337773B2 (en) | 2017-07-29 | 2023-09-04 | ジュノー セラピューティクス インコーポレイテッド | Reagents for expanding cells expressing recombinant receptors |
CN111542596A (en) | 2017-11-01 | 2020-08-14 | 朱诺治疗学股份有限公司 | Methods of producing therapeutic compositions of engineered cells |
JP7258899B2 (en) | 2017-11-01 | 2023-04-17 | ジュノー セラピューティクス インコーポレイテッド | Methods for making T cell compositions |
CN112004824B (en) | 2017-12-08 | 2024-09-13 | 朱诺治疗学股份有限公司 | Process for producing engineered T cell compositions |
CN115087868A (en) | 2019-11-05 | 2022-09-20 | 朱诺治疗学股份有限公司 | Methods of determining attributes of therapeutic T cell compositions |
US20230144097A1 (en) * | 2020-03-30 | 2023-05-11 | Institute Of Zoology, Chinese Academy Of Sciences | Active dna transposon systems and methods for use thereof |
CN115803824A (en) | 2020-05-13 | 2023-03-14 | 朱诺治疗学股份有限公司 | Methods of identifying characteristics associated with clinical response and uses thereof |
AU2022241654A1 (en) | 2021-03-22 | 2023-09-28 | Juno Therapeutics, Inc. | Methods of determining potency of a therapeutic cell composition |
WO2023122716A1 (en) | 2021-12-22 | 2023-06-29 | Vanderbilt University | Next generation transpososomes |
WO2023230548A1 (en) | 2022-05-25 | 2023-11-30 | Celgene Corporation | Method for predicting response to a t cell therapy |
WO2023230272A1 (en) | 2022-05-27 | 2023-11-30 | Kite Pharma, Inc. | Non-viral delivery of cell therapy constructs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU731615B2 (en) * | 1996-02-09 | 2001-04-05 | Het Nederlands Kanker Instituut | Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
DK0973928T3 (en) * | 1997-03-11 | 2010-08-09 | Univ Minnesota | DNA-based transposon system for introducing nucleic acid into DNA in a cell |
-
1998
- 1998-11-13 JP JP2000521183A patent/JP2001523450A/en not_active Withdrawn
- 1998-11-13 AU AU14103/99A patent/AU1410399A/en not_active Abandoned
- 1998-11-13 CA CA002309000A patent/CA2309000A1/en not_active Abandoned
- 1998-11-13 WO PCT/US1998/024348 patent/WO1999025817A2/en not_active Application Discontinuation
- 1998-11-13 EP EP98957974A patent/EP1034258A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2309000A1 (en) | 1999-05-27 |
WO1999025817A3 (en) | 1999-08-05 |
WO1999025817A2 (en) | 1999-05-27 |
EP1034258A2 (en) | 2000-09-13 |
WO1999025817A9 (en) | 1999-09-10 |
JP2001523450A (en) | 2001-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1410399A (en) | Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell | |
AU9570898A (en) | Chemical modification of dna using peptide nucleic acid conjugates | |
AU6096896A (en) | Modified nucleotides for nucleic acid labeling | |
AU7542498A (en) | Nucleic acid binding proteins | |
AU7225591A (en) | Nucleic acid enzymes for cleaving dna | |
AU6058094A (en) | Internal controls for iosthermal nucleic acid amplification reactions | |
HUP0001937A3 (en) | Compounds, preparation and use for transferring nucleic acids into cells | |
AU5539898A (en) | Nucleic acid construct for the cell cycle regulated expression of structural genes | |
AU6591798A (en) | Nucleic acid catalysts | |
AU1115200A (en) | Nucleic acid arrays | |
AU4289399A (en) | Nucleic acid transfer phage | |
IL130886A0 (en) | Nucleic acid sequencing | |
AU9100598A (en) | Method for the preparation of a probe for nucleic acid hybridization | |
AU6229498A (en) | Composition for gene introduction into cell | |
AU2315195A (en) | Nucleic acid mutation assays | |
AU7962398A (en) | Mammalian genes; related reagents | |
AU8234898A (en) | Characterising nucleic acid | |
AU7208394A (en) | Improved nucleic acid reactions | |
AU7813698A (en) | Nucleic acid detection | |
AU6152000A (en) | Copolymers for the transfer of nucleic acids to the cell | |
AU5905094A (en) | Nucleic acid assay procedure | |
AU6376698A (en) | Improved nucleic acid assays | |
AU1029099A (en) | Transfection system for the transfer of nucleic acids into cells | |
AU2021800A (en) | Mammalian genes; related reagents | |
GB9713122D0 (en) | Novel method of DNA transfer into cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |